Sinopharm
1099.HK
#1957
Rank
โ‚น695.59 B
Marketcap
โ‚น222.90
Share price
-3.52%
Change (1 day)
6.58%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : โ‚น881.14 Billion

According to Sinopharm's latest financial reports the company's total debt is โ‚น881.14 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2022-12-31โ‚น1.133 T41.99%
2021-12-31โ‚น798.59 B3.93%
2020-12-31โ‚น768.39 B36.51%
2019-12-31โ‚น562.86 B0.47%
2018-12-31โ‚น560.26 B53.27%
2017-12-31โ‚น365.52 B11.5%
2016-12-31โ‚น327.82 B10.39%
2015-12-31โ‚น296.97 B-1.5%
2014-12-31โ‚น301.49 B17.47%
2013-12-31โ‚น256.65 B81.08%
2012-12-31โ‚น141.73 B21.59%
2011-12-31โ‚น116.56 B400.75%
2010-12-31โ‚น23.27 B99.38%
2009-12-31โ‚น11.67 B1.28%
2008-12-31โ‚น11.52 B-7.62%
2007-12-31โ‚น12.47 B16.86%
2006-12-31โ‚น10.67 B